
LIXT Valuation
Lixte Biotechnology Holdings Inc
- Overview
- Forecast
- Valuation
- Earnings
LIXT Relative Valuation
LIXT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LIXT is overvalued; if below, it's undervalued.
Historical Valuation
Lixte Biotechnology Holdings Inc (LIXT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Lixte Biotechnology Holdings Inc (LIXT) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:4.21
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-4.76
P/B
Median3y
0.99
Median5y
-24.23
-12.95
FCF Yield
Median3y
-67.66
Median5y
-46.44
Competitors Valuation Multiple
The average P/S ratio for LIXT's competitors is 50.18, providing a benchmark for relative valuation. Lixte Biotechnology Holdings Inc Corp (LIXT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

GPUS
Hyperscale Data Inc
0.800
USD
-8.68%

SNTG
Sentage Holdings Inc
1.935
USD
0.00%

AMBO
Ambow Education Holding Ltd
2.770
USD
-2.29%

BAOS
Baosheng Media Group Holdings Ltd
2.920
USD
-1.35%

CISS
C3is Inc
3.510
USD
0.00%

IVP
Inspire Veterinary Partners Inc
0.701
USD
-7.03%

VINC
Vincerx Pharma Inc
0.064
USD
-33.00%

KWE
Kwesst Micro Systems Inc
11.360
USD
-1.38%

STAF
Staffing 360 Solutions Inc
1.615
USD
0.00%

CETX
Cemtrex Inc
1.232
USD
-1.44%
FAQ

Is Lixte Biotechnology Holdings Inc (LIXT) currently overvalued or undervalued?
Lixte Biotechnology Holdings Inc (LIXT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Lixte Biotechnology Holdings Inc (LIXT) is between to according to relative valuation methord.

What is Lixte Biotechnology Holdings Inc (LIXT) fair value?

How does LIXT's valuation metrics compare to the industry average?

What is the current P/B ratio for Lixte Biotechnology Holdings Inc (LIXT) as of Jul 25 2025?

What is the current FCF Yield for Lixte Biotechnology Holdings Inc (LIXT) as of Jul 25 2025?

What is the current Forward P/E ratio for Lixte Biotechnology Holdings Inc (LIXT) as of Jul 25 2025?
